Forte Biosciences, Inc. (FBRX) Total Assets by Year
Forte Biosciences, Inc. closed fiscal year 2025 with $82.8M in total assets, $21.8M in total liabilities and $61.0M in shareholder equity. This represents an increase of 34.5% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Forte Biosciences, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
FBRX Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25DEF 14A | FY24DEF 14A | FY23DEF 14A | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $82.8M+34.5% | $61.6M+57.9% | $39.0M-7.2% | $42.0M-3.0% | $43.3M-29.3% | $61.2M+699.7% | $7.7M-92.6% | $103.1M+12.0% | $92.1M+160.5% | $35.4M | N/A |
| Total Liabilities | $21.8M+139.9% | $9.1M+147.7% | $3.7M+15.3% | $3.2M+80.8% | $1.8M-22.2% | $2.3M-81.8% | $12.4M-88.0% | $103.8M+394.6% | $21.0M-86.9% | $159.8M | N/A |
| Total Equity | $61.0M+16.2% | $52.5M+48.6% | $35.3M-9.0% | $38.8M-6.6% | $41.5M-29.6% | $59.0M+1336.7% | -$4.8M-548.0% | -$736K-101.0% | $71.1M+157.1% | -$124.4M-34.8% | -$92.3M |
FBRX Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $205.7M+90.9% | $67.2M+41.6% | $82.8M+34.5% | $97.1M+441.0% | $107.8M+313.3% | $47.5M+48.2% | $61.6M+57.9% | $17.9M-62.5% | $26.1M-16.4% | $32.0M-12.8% | $39.0M-7.2% | $47.9M+6.1% |
| Total Liabilities | $21.9M+139.4% | $25.1M+178.2% | $21.8M+139.9% | $13.0M+51.4% | $9.2M+0.6% | $9.0M+171.1% | $9.1M+147.7% | $8.6M+14.8% | $9.1M+44.7% | $3.3M-11.4% | $3.7M+15.3% | $7.5M+225.8% |
| Total Equity | $183.8M+86.4% | $42.1M+9.6% | $61.0M+16.2% | $84.1M+797.9% | $98.6M+481.4% | $38.4M+34.0% | $52.5M+48.6% | $9.4M-76.8% | $17.0M-31.8% | $28.7M-12.9% | $35.3M-9.0% | $40.4M-5.7% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Forte Biosciences, Inc. financials
Frequently Asked Questions
What was Forte Biosciences, Inc.'s total assets in fiscal year 2025?
Forte Biosciences, Inc. closed fiscal year 2025 with $82.8M in total assets, $21.8M in total liabilities and $61.0M in shareholder equity.
How fast is Forte Biosciences, Inc.'s total assets growing?
Forte Biosciences, Inc. (FBRX) total assets rose by 34.5% year over year, from $61.6M to $82.8M in fiscal year 2025.
What was Forte Biosciences, Inc.'s total assets in the most recent quarter?
Forte Biosciences, Inc. (FBRX) reported $205.7M in total assets in Q2 2026. This represents an increase of 90.9% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Forte Biosciences, Inc. (FBRX) reported on that line in every period on record.